Clinical Trials Browser

Phase 2/3 × irinotecan sucrosofate × 1 year × Clear all

NCT07585279 2026-05-13

A Clinical Study of Liposomal Irinotecan for Second-Line Therapy in Metastatic Colorectal Cancer

Phase 2/3 Not yet recruiting

Gastrointestinal

Colorectal Neoplasms